Collecting data on rare and complex tumors in the thoraco-abdominal region
Evaluation of Rare and Complex Tumours of the Thoraco-Abdominal and Soft Tissue District - Observational Study With Retrospective and Prospective Phase
This study is collecting information on rare and complex tumors in the chest and abdomen to better understand how they are diagnosed, treated, and followed up over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna Academic / other |
| Locations | 2 sites (Bologna, BO and 1 other locations) |
| Trial ID | NCT06872853 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather structured data regarding the diagnosis, treatment, and follow-up of rare and complex malignant neoplasms. It includes a retrospective component that collects data from patients treated at the IRCCS Azienda Ospedaliero-Universitaria di Bologna from January 1, 2000, to September 28, 2017, as well as a prospective component extending to December 31, 2025. The study focuses on understanding the clinical pathways and outcomes associated with these rare tumors.
Who should consider this trial
Good fit: Ideal candidates for this study are patients with a histologic diagnosis of rare or highly complex malignant neoplasms.
Not a fit: Patients without a histologic diagnosis of rare malignant neoplasms will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding and management of rare malignant neoplasms, leading to improved patient outcomes.
How similar studies have performed: While there may be limited studies specifically targeting rare tumors, observational studies in oncology have shown success in improving treatment protocols and patient outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients with histologic diagnosis of rare or highly complex malignant neoplasm * informed consent Exclusion Criteria: * none
Where this trial is running
Bologna, BO and 1 other locations
- Oncology Unit, IRCCS AOUBO Policlinico di S. Orsola — Bologna, Bo, Italy (Recruiting)
- Thoracic Surgery Unit — Bologna, Bo, Italy (Recruiting)
Study contacts
- Principal investigator: Maria A Pantaleo, MD — Oncology Unit, IRCCS AOUBO
- Study coordinator: Maria A Pantaleo, MD
- Email: maria.pantaleo@unibo.it
- Phone: +39 051 214
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.